These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 26522917)
1. Evaluation of the activity and substrate specificity of the human SENP family of SUMO proteases. Mendes AV; Grou CP; Azevedo JE; Pinto MP Biochim Biophys Acta; 2016 Jan; 1863(1):139-47. PubMed ID: 26522917 [TBL] [Abstract][Full Text] [Related]
2. Small ubiquitin-related modifier (SUMO)-specific proteases: profiling the specificities and activities of human SENPs. Mikolajczyk J; Drag M; Békés M; Cao JT; Ronai Z; Salvesen GS J Biol Chem; 2007 Sep; 282(36):26217-24. PubMed ID: 17591783 [TBL] [Abstract][Full Text] [Related]
7. Activity profiling of human deSUMOylating enzymes (SENPs) with synthetic substrates suggests an unexpected specificity of two newly characterized members of the family. Drag M; Mikolajczyk J; Krishnakumar IM; Huang Z; Salvesen GS Biochem J; 2008 Jan; 409(2):461-9. PubMed ID: 17916063 [TBL] [Abstract][Full Text] [Related]
8. Mapping residues of SUMO precursors essential in differential maturation by SUMO-specific protease, SENP1. Xu Z; Au SW Biochem J; 2005 Mar; 386(Pt 2):325-30. PubMed ID: 15487983 [TBL] [Abstract][Full Text] [Related]
9. Identification and developmental expression of Xenopus laevis SUMO proteases. Wang Y; Mukhopadhyay D; Mathew S; Hasebe T; Heimeier RA; Azuma Y; Kolli N; Shi YB; Wilkinson KD; Dasso M PLoS One; 2009 Dec; 4(12):e8462. PubMed ID: 20041154 [TBL] [Abstract][Full Text] [Related]
10. SUMO proteases as potential targets for cancer therapy. Bialik P; Woźniak K Postepy Hig Med Dosw (Online); 2017 Dec; 71(0):997-1004. PubMed ID: 29225200 [TBL] [Abstract][Full Text] [Related]
11. In Vitro Characterization of Chain Depolymerization Activities of SUMO-Specific Proteases. Eckhoff J; Dohmen RJ Methods Mol Biol; 2016; 1475():123-35. PubMed ID: 27631802 [TBL] [Abstract][Full Text] [Related]
12. Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3. Gong L; Yeh ET J Biol Chem; 2006 Jun; 281(23):15869-77. PubMed ID: 16608850 [TBL] [Abstract][Full Text] [Related]
13. Development of small molecule inhibitors and probes of human SUMO deconjugating proteases. Albrow VE; Ponder EL; Fasci D; Békés M; Deu E; Salvesen GS; Bogyo M Chem Biol; 2011 Jun; 18(6):722-32. PubMed ID: 21700208 [TBL] [Abstract][Full Text] [Related]
14. Sentrin/SUMO specific proteases as novel tissue-selective modulators of vitamin D receptor-mediated signaling. Lee WP; Jena S; Doherty D; Ventakesh J; Schimdt J; Furmick J; Widener T; Lemau J; Jurutka PW; Thompson PD PLoS One; 2014; 9(2):e89506. PubMed ID: 24586832 [TBL] [Abstract][Full Text] [Related]
15. Swapping small ubiquitin-like modifier (SUMO) isoform specificity of SUMO proteases SENP6 and SENP7. Alegre KO; Reverter D J Biol Chem; 2011 Oct; 286(41):36142-36151. PubMed ID: 21878624 [TBL] [Abstract][Full Text] [Related]
16. Senp1 is essential for desumoylating Sumo1-modified proteins but dispensable for Sumo2 and Sumo3 deconjugation in the mouse embryo. Sharma P; Yamada S; Lualdi M; Dasso M; Kuehn MR Cell Rep; 2013 May; 3(5):1640-50. PubMed ID: 23684609 [TBL] [Abstract][Full Text] [Related]
17. Emerging roles of desumoylating enzymes. Kim JH; Baek SH Biochim Biophys Acta; 2009 Mar; 1792(3):155-62. PubMed ID: 19162180 [TBL] [Abstract][Full Text] [Related]
18. The SUMO-specific protease SENP5 is required for cell division. Di Bacco A; Ouyang J; Lee HY; Catic A; Ploegh H; Gill G Mol Cell Biol; 2006 Jun; 26(12):4489-98. PubMed ID: 16738315 [TBL] [Abstract][Full Text] [Related]